Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Mo | Silynxcom Ltd. Announces Proposed Public Offering of Ordinary Shares | ||
Mo | Fibrobiologics, Inc.: FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update | ||
Mo | Orchestra BioMed Holdings, Inc.: Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update | ||
Mo | Vivos Therapeutics, Inc: Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update | ||
Mo | Cue Biopharma, Inc.: Cue Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights | ||
Mo | ECARX Holdings Inc. Announces Completion of Offering of 25,000,000 Class A Ordinary Shares | ||
Mo | AgEagle Aerial Systems, Inc.: AgEagle Aerial Systems Provides a Corporate Update and Reports Fiscal 2024 Financial Results | ||
Mo | Wrap Technologies, Inc. Reports Fourth Quarter and Full Year 2024 Results | ||
Mo | Xtreme One Entertainment, Inc.: Xtreme One Entertainment Announces Full Year 2024 Financial Results | ||
Mo | Norwood Financial Corp Announces Cash Dividend | ||
Mo | Binah Capital Group Reports Fourth Quarter and Full Year 2024 Results | ||
Mo | Rail Vision Ltd.: Rail Vision Announces Second Half and Full Year 2024 Financial Results: Reports Strong Revenue Growth for the Full Year 2024, Driven by Key Orders and Market Expansion | ||
Mo | AleAnna, Inc. Reports Fiscal Year 2024 Results | ||
Mo | Duos Technologies Group, Inc: Duos Technologies Group Reports 4th Quarter and FY 2024 Results | ||
Mo | Nova LifeStyle, Inc.: Nova LifeStyle Announces Fiscal 2024 Financial Results | ||
Mo | Zevra Therapeutics Files Preliminary Proxy | ||
Mo | Ellomay Capital Ltd: Ellomay Capital Reports Publication of Financial Statements of Dorad Energy Ltd. for the Year Ended December 31, 2024 | ||
Mo | Archimedes Tech SPAC Partners II Co. Announces the Separate Trading of its Ordinary Shares and Warrants Commencing April 3, 2025 | ||
Mo | Biomea Fusion, Inc.: Biomea Fusion Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights | ||
Mo | Calidi Biotherapeutics, Inc: Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Operational Highlights | ||
Mo | Aardvark Therapeutics, Inc.: Aardvark Therapeutics Reports Full Year 2024 Financial Results and Provides Business Highlights | ||
Mo | IDEX Biometrics ASA - Information about the second exercise period for warrants (Warrants B) issued in connection with the Private Placement and Subsequent Offering | ||
Mo | Wintrust Financial Corporation Announces First Quarter 2025 Earnings Release Schedule | ||
Mo | Wendel completes the acquisition of a controlling stake in Monroe Capital LLC, a transformational transaction in line with its strategic roadmap | ||
Mo | Surrozen, Inc.: Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates |